Immune-related adverse events (irAE) to cancer immune checkpoint inhibitors (CPI) and survival outcomes: To rechallenge or not—An Appalachian experience.

Heidar Albandar,Salah Ud Din Safi,Jacob Lane Fuqua,Samuel Merrill,Patrick C. Ma

Journal of Clinical Oncology（2020）

引用 0|浏览0

暂无评分

摘要

81Background: The adoption of immunotherapy has led to a paradigm shift in the treatment of many advanced stage malignancies. Patients with durable long term survival under cancer immunotherapy hav...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要